A Brisbane couple was forced into silence after giving birth to a biracial baby in a sperm mix-up at one of Australia’s largest IVF providers, Queensland Fertility Group (QFG). The 2014 incident remained secret for 11 years until uncovered by an ABC investigation.
The couple, both Caucasian, had selected a sperm donor whose description matched the husband’s features — fair hair and blue eyes. They only realised something was wrong when their child was born of a different ethnicity.
According to multiple sources, QFG, owned by fertility giant Virtus Health, paid the couple a settlement in exchange for signing a strict non-disclosure agreement. The case was never disclosed to shareholders, despite Virtus being a publicly listed company at the time.
U.S. sperm bank error confirmed
An internal investigation by Seattle Sperm Bank later confirmed that two donors — one Caucasian, one African American — gave samples on the same day. A mislabelling error led to the wrong specimen being used.
The sperm bank admitted its laboratory had not followed the industry-standard double-witnessing process, which was already mandatory in Australia. It has since implemented a seven-step automated verification system.
QFG stated all remaining sperm from the donor was destroyed.
Family left unsupported
Friends of the couple said the parents were left feeling abandoned.
“They went to the clinic three times, and the clinic dismissed them,” said family friend Jo Bastian. “The mother felt very isolated. There was no contact to see how she and the baby were going.”
QFG later acknowledged that “greater support and communication” should have been provided.
Regulator and transparency concerns
The Reproductive Technology Accreditation Committee (RTAC), the sector’s regulator, confirmed it had “no formal knowledge” of the incident and that reporting was not required at the time. Critics say the case highlights a lack of transparency and oversight in the industry.
Fertility researcher Dr Karin Hammarberg warned that secrecy undermines public trust.
“We have no way of knowing the extent of adverse events or what’s done to prevent them,” she said. “We have to take learnings from mistakes.”
Shareholder disclosure avoided
Despite legal obligations to the stock exchange, Virtus Health did not disclose the mix-up to investors. The Australian Shareholders Association called for stronger transparency in healthcare companies.
Virtus has since been taken private in a $655 million buyout by BGH Capital.
Calls for reform
The case has intensified pressure on governments to strengthen regulation of the IVF sector. Health ministers launched a national review in June, and experts are urging the creation of an independent regulator to replace the industry-funded RTAC.
Meanwhile, an audit has revealed thousands of QFG’s pre-2020 semen samples were at risk of misidentification due to poor safeguards.
For the couple involved, the ordeal has left scars despite their love for their child.
“You put your trust in the clinic to get it right,” said Ms Bastian. “But these things are still happening. They should have got it right by now.”
YOU MAY ALSO LIKE
Researchers Urge IVF Chromosome Screening on NHS for Older Women
Federal and State Policies Expand Access to IVF Nationwide
Telehealth CBT Therapy Shows Lasting Relief for Chronic Pain Patients
